This titrate-up and taper-down controversy stems from concerns regarding the potential for hyperglycemia upon initiation of total parenteral nutrition (TPN) and for hypoglycemia upon discontinuation.
The adequacy of the recommended parenteral intakes of Zn and Cu was studied in 12 infants (X±SE: 3.3±1.4 mo, range 0.25-17 mo) who were NPO and who received TPN supplemented with Zn and Cu (100 ...
As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in the first participating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback